Detection of C-Peptide in Urine as a Measure of Ongoing Beta Cell Function.

about

Detection of C-Peptide in Urine as a Measure of Ongoing Beta Cell Function.

Item

http://www.wikidata.org/entity/Q52874770

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Detection of C-Peptide in Urine as a Measure of Ongoing Beta Cell Function.

@en

Detection of C-Peptide in Urine as a Measure of Ongoing Beta Cell Function.

@nl

type

Item

label

Detection of C-Peptide in Urine as a Measure of Ongoing Beta Cell Function.

@en

Detection of C-Peptide in Urine as a Measure of Ongoing Beta Cell Function.

@nl

prefLabel

Detection of C-Peptide in Urine as a Measure of Ongoing Beta Cell Function.

@en

Detection of C-Peptide in Urine as a Measure of Ongoing Beta Cell Function.

@nl

P1476

Detection of C-Peptide in Urine as a Measure of Ongoing Beta Cell Function.

@en

P2093

M H Perry

http://www.w3.org/2001/XMLSchema#string

P2860

Urine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational study

Assays for insulin, proinsulin(s) and C-peptide.

Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes.

EDTA improves stability of whole blood C-peptide and insulin to over 24 hours at room temperature.

Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.

Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes.

Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young.

Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes.

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes

The diagnosis and management of monogenic diabetes in children and adolescents.

P304

93-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/7651_2016_330

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

1433

http://www.w3.org/2001/XMLSchema#string

P50

Timothy J McDonald

P577

2016-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27083170

http://www.w3.org/2001/XMLSchema#string